BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31750732)

  • 21. Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer.
    Duan J; Pan Y; Yang X; Zhong L; Jin Y; Xu J; Zhuang J; Han S
    Biomed Res Int; 2020; 2020():5816763. PubMed ID: 33274216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
    Tang H; Wang Z; Shao Q; Wang Y; Yang Q
    Med Sci Monit; 2020 Jun; 26():e922676. PubMed ID: 32533823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
    Wu X; Ruan L; Yang Y; Mei Q
    Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
    Zhao W; Wang J; Luo Q; Peng W; Li B; Wang L; Zhang C; Duan C
    BMC Med Genomics; 2020 Dec; 13(1):185. PubMed ID: 33308216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
    Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J
    J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
    Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.
    Guo L; Li H; Li W; Tang J
    BMC Med Genomics; 2020 Nov; 13(1):166. PubMed ID: 33148251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
    Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
    PeerJ; 2019; 7():e8024. PubMed ID: 31720124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
    Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
    Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
    Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
    Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma.
    Lyu K; Li Y; Xu Y; Yue H; Wen Y; Liu T; Chen S; Liu Q; Yang W; Zhu X; Wang Z; Chai L; Wen W; Li C; Lei W
    RNA Biol; 2020 Jul; 17(7):977-989. PubMed ID: 32174248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
    Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
    Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.